Skip to main content

Tim Casey

News Connection
06/26/2013
Bruce Feinberg, DO, initially participated in a program focused on standardizing care for cancer patients in 1994. As the founder of Georgia Cancer Specialists, a group of oncologists based in Atlanta, he implemented a system in which...
Bruce Feinberg, DO, initially participated in a program focused on standardizing care for cancer patients in 1994. As the founder of Georgia Cancer Specialists, a group of oncologists based in Atlanta, he implemented a system in which...
Bruce Feinberg, DO, initially...
06/26/2013
First Report Managed Care
07/22/2014
Irritable bowel syndrome (IBS), is a disorder associated with abdominal pain and discomfort and an altered bowel habit.
Irritable bowel syndrome (IBS), is a disorder associated with abdominal pain and discomfort and an altered bowel habit.
Irritable bowel syndrome (IBS),...
07/22/2014
First Report Managed Care
02/19/2014
New Orleans—After at least 24 months of follow-up, heavily pretreated patients with chronic phase or accelerated phase chronic myeloid leukemia (CML) had clinically meaningful and durable responses to omacetaxine, according to a subset...
New Orleans—After at least 24 months of follow-up, heavily pretreated patients with chronic phase or accelerated phase chronic myeloid leukemia (CML) had clinically meaningful and durable responses to omacetaxine, according to a subset...
New Orleans—After at least 24...
02/19/2014
First Report Managed Care
09/19/2013
Opioid medications have been proven effective in treating chronic pain; however, they are also associated with misuse, abuse, and diversion. 
Opioid medications have been proven effective in treating chronic pain; however, they are also associated with misuse, abuse, and diversion. 
Opioid medications have been...
09/19/2013
First Report Managed Care
News
05/17/2013
As the FDA approves more drugs to treat multiple sclerosis, healthcare professionals are attempting to understand the costs, benefits, and risks associated with the various treatment options.
As the FDA approves more drugs to treat multiple sclerosis, healthcare professionals are attempting to understand the costs, benefits, and risks associated with the various treatment options.
As the FDA approves more drugs...
05/17/2013
First Report Managed Care
01/22/2013
Atlanta—Patients with mantle cell lymphoma who took lenalidomide had a 35% overall response rate to the drug and median progression-free survival of 8.8 months, according to a subset analysis of a phase 2, single-arm, open-label,...
Atlanta—Patients with mantle cell lymphoma who took lenalidomide had a 35% overall response rate to the drug and median progression-free survival of 8.8 months, according to a subset analysis of a phase 2, single-arm, open-label,...
Atlanta—Patients with mantle...
01/22/2013
First Report Managed Care
10/22/2012
In a fee-for-service payment system, physicians are compensated for each test and procedure, creating an environment in which they are incentivized for the volume of care they provide. This situation has led to frustration for both patients...
In a fee-for-service payment system, physicians are compensated for each test and procedure, creating an environment in which they are incentivized for the volume of care they provide. This situation has led to frustration for both patients...
In a fee-for-service payment...
10/22/2012
First Report Managed Care
06/19/2012
Orlando—In nearly 5 decades as a doctor, Sam JW Romeo has seen numerous industry innovations that did not improve care or cut costs. He is now the medical director at Tower Health & Wellness Center in Turlock, California, which he and other...
Orlando—In nearly 5 decades as a doctor, Sam JW Romeo has seen numerous industry innovations that did not improve care or cut costs. He is now the medical director at Tower Health & Wellness Center in Turlock, California, which he and other...
Orlando—In nearly 5 decades as a...
06/19/2012
First Report Managed Care
News
01/25/2012
Madrid—According to an interactive tool developed to estimate the first-year cost of administering and monitoring multiple sclerosis (MS) therapies, glatiramer acetate was the cheapest treatment option, followed by interferon beta-1a...
Madrid—According to an interactive tool developed to estimate the first-year cost of administering and monitoring multiple sclerosis (MS) therapies, glatiramer acetate was the cheapest treatment option, followed by interferon beta-1a...
Madrid—According to an...
01/25/2012
First Report Managed Care
10/14/2011
Although the accurate number and dollar value of counterfeit drugs are difficult to quantify, the issue has received attention recently in the United States because pharmaceutical companies are becoming more internationally based and because...
Although the accurate number and dollar value of counterfeit drugs are difficult to quantify, the issue has received attention recently in the United States because pharmaceutical companies are becoming more internationally based and because...
Although the accurate number and...
10/14/2011
First Report Managed Care